95 related articles for article (PubMed ID: 24956865)
1. [Infect of pingshen decoction on serum HGF, Cys C and TGF-beta1 diabetic nephropathy in early stage].
Bao HL; Ye SH; Lou SX; Lu XW; Zhou XF
Zhongguo Zhong Yao Za Zhi; 2014 Mar; 39(6):1128-31. PubMed ID: 24956865
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta 1 in diabetic nephropathy.
Metwally SS; Mosaad YM; Nassr AA; Zaki OM
Egypt J Immunol; 2005; 12(1):103-12. PubMed ID: 16734145
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
Eur Cytokine Netw; 2001; 12(3):445-52. PubMed ID: 11566625
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor suppresses transforming growth factor-beta-1 and type III collagen in human primary renal fibroblasts.
Mou S; Wang Q; Shi B; Gu L; Ni Z
Kaohsiung J Med Sci; 2009 Nov; 25(11):577-87. PubMed ID: 19858036
[TBL] [Abstract][Full Text] [Related]
5. Measurement of urinary TGF-β1 in patients with diabetes mellitus and normal controls.
Tsapenko MV; Nwoko RE; Borland TM; Voskoboev NV; Pflueger A; Rule AD; Lieske JC
Clin Biochem; 2013 Oct; 46(15):1430-5. PubMed ID: 23685222
[TBL] [Abstract][Full Text] [Related]
6. [Clinical study on treatment of early diabetic nephropathy by tangshenling combined with telmisartan].
Li JP; He XL; Li Q
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 May; 26(5):415-8. PubMed ID: 16883907
[TBL] [Abstract][Full Text] [Related]
7. Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.
Mizuno S; Nakamura T
Am J Physiol Renal Physiol; 2004 Jan; 286(1):F134-43. PubMed ID: 14519594
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte growth factor and transforming growth factor beta1 contribute to regeneration of small-for-size liver graft immediately after transplantation.
Ninomiya M; Harada N; Shiotani S; Hiroshige S; Minagawa R; Soejima Y; Suehiro T; Nishizaki T; Shimada M; Sugimachi K
Transpl Int; 2003 Nov; 16(11):814-9. PubMed ID: 12879228
[TBL] [Abstract][Full Text] [Related]
9. Effect of catalpol on diabetic nephropathy in rats.
Dong Z; Chen CX
Phytomedicine; 2013 Aug; 20(11):1023-9. PubMed ID: 23746755
[TBL] [Abstract][Full Text] [Related]
10. [Effect on transforming growth factor-beta1 of glucocorticoid-induced avascular necrosis of femoral head in rats by treatment of activating blood circulation of Chinese herbal medicine].
Qi ZX; Kang JD; Li SQ
Zhongguo Gu Shang; 2009 Aug; 22(8):596-8. PubMed ID: 19753978
[TBL] [Abstract][Full Text] [Related]
11. Quercetin ameliorates diabetic nephropathy by reducing the expressions of transforming growth factor-β1 and connective tissue growth factor in streptozotocin-induced diabetic rats.
Lai PB; Zhang L; Yang LY
Ren Fail; 2012; 34(1):83-7. PubMed ID: 22011322
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta 1 and monocyte chemoattractant protein-1 as prognostic markers of diabetic nephropathy.
Shaker OG; Sadik NA
Hum Exp Toxicol; 2013 Oct; 32(10):1089-96. PubMed ID: 23515495
[TBL] [Abstract][Full Text] [Related]
13. [Effects of bushen tongdu decoction on serum tumor necrosis factor-alpha and transforming growth factor beta1, in patients with ankylosing spondylitis].
Xu JR; Zhang CY; Li WM
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Dec; 28(12):1093-5. PubMed ID: 19317165
[TBL] [Abstract][Full Text] [Related]
14. Gene polymorphism of transforming growth factor-β1 in Egyptian patients with type 2 diabetes and diabetic nephropathy.
El-Sherbini SM; Shahen SM; Mosaad YM; Abdelgawad MS; Talaat RM
Acta Biochim Biophys Sin (Shanghai); 2013 Apr; 45(4):330-8. PubMed ID: 23399816
[TBL] [Abstract][Full Text] [Related]
15. Transient reciprocal change of renal hepatocyte growth factor and transforming growth factor-beta1 may relate to renal hypertrophy in rats with liver injury or unilateral nephrectomy.
Tsau YK; Tsai IJ; Chen YM
Pediatr Res; 2006 Apr; 59(4 Pt 1):494-9. PubMed ID: 16549518
[TBL] [Abstract][Full Text] [Related]
16. Intravenous administration of hepatocyte growth factor gene ameliorates diabetic nephropathy in mice.
Dai C; Yang J; Bastacky S; Xia J; Li Y; Liu Y
J Am Soc Nephrol; 2004 Oct; 15(10):2637-47. PubMed ID: 15466268
[TBL] [Abstract][Full Text] [Related]
17. [Effect of selective cyclooxygenase -2 inhibitor on the renal lesion of streptozotocin-induced diabetic rats and its possible mechanism].
Zuo Y; Gu Y; Ma J; Lin S
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):239-43. PubMed ID: 11953170
[TBL] [Abstract][Full Text] [Related]
18. [Dilingdan Decoction prevents renal interstitial fibrosis in a rat model of unilateral ureteral obstruction].
Huan HD; Zhang JH; Zheng SR; Meng WW; Zhang JL
Zhong Xi Yi Jie He Xue Bao; 2008 May; 6(5):493-7. PubMed ID: 18471414
[TBL] [Abstract][Full Text] [Related]
19. Nephromegaly relates to hepatocyte growth factor dysregulation in biliary atresia.
Tsau YK; Jou ST; Ni YH
Pediatr Nephrol; 2002 Jul; 17(7):554-9. PubMed ID: 12172775
[TBL] [Abstract][Full Text] [Related]
20. [Clinical study on effect of tongluo capsule in treating diabetic nephropathy caused chronic renal failure].
Sun WS; Wu XL; Qiao CL
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Aug; 24(8):704-6. PubMed ID: 15366593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
